Teachers Advisors’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-281,597
| Closed | -$99K | – | 3141 |
|
|
2016
Q3 | $99K | Hold |
281,597
| – | – | ﹤0.01% | 3005 |
|
|
2016
Q2 | $131K | Buy |
281,597
+22,170
| +9% | +$10.3K | ﹤0.01% | 3010 |
|
|
2016
Q1 | $353K | Hold |
259,427
| – | – | ﹤0.01% | 2534 |
|
|
2015
Q4 | $381K | Hold |
259,427
| – | – | ﹤0.01% | 2567 |
|
|
2015
Q3 | $410K | Buy |
259,427
+15,338
| +6% | +$24.2K | ﹤0.01% | 2511 |
|
|
2015
Q2 | $415K | Buy |
244,089
+70,250
| +40% | +$119K | ﹤0.01% | 2632 |
|
|
2015
Q1 | $242K | Buy |
173,839
+8,721
| +5% | +$12.1K | ﹤0.01% | 2808 |
|
|
2014
Q4 | $249K | Hold |
165,118
| – | – | ﹤0.01% | 2811 |
|
|
2014
Q3 | $340K | Hold |
165,118
| – | – | ﹤0.01% | 2609 |
|
|
2014
Q2 | $505K | Sell |
165,118
-25,486
| -13% | -$77.9K | ﹤0.01% | 2424 |
|
|
2014
Q1 | $477K | Buy |
190,604
+45,050
| +31% | +$113K | ﹤0.01% | 2430 |
|
|
2013
Q4 | $722K | Sell |
145,554
-8,687
| -6% | -$43.1K | ﹤0.01% | 2172 |
|
|
2013
Q3 | $350K | Buy |
154,241
+47,235
| +44% | +$107K | ﹤0.01% | 2538 |
|
|
2013
Q2 | $238K | Buy |
+107,006
| New | +$238K | ﹤0.01% | 2667 |
|
Teachers Advisors's RXII Position: Q4 2016 in Review
Teachers Advisors sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 281,597 shares — an estimated $99K sold.
Teachers Advisors first reported a position in RXII in Q2 2013 and held it in 14 quarters. The position peaked at $722K in Q4 2013. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.
- Teachers Advisors reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
- Teachers Advisors sold 281,597 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $99K.
- Teachers Advisors first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 14 quarters.
- Teachers Advisors's GALENA BIOPHARMA INC COM position peaked at $722K in Q4 2013.
- 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.
Based on Teachers Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.